EPT Disclosure

17 May 2006 12:31

Deutsche Bank AG London17 May 2006 FORM 38.5 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS (Rule 38.5 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the dealings Ordinarybeing disclosed relate (Note 1) Date of dealing 16/05/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 630,788 £13.02 £13.00 Total number of securities Sold Highest price received (Note 3) Lowest price received (Note 3) 11,082 £13.005 £13.00 (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)CFD CFD Long 33,533 £13.0029CFD Long 26,894 £12.98CFD Long 200,000 £13.00CFD Long 264,845 £12.994262CFD Short 3,826 £12.99CFD Short 36 £12.975 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name,e.g. Writing, Number of Exercise Type, e.g. Expiry Option moneycall option selling, securities to price American, date paid/received purchasing, which the option European etc. per unit (Note varying etc. relates (Note 5) 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. ..................................................................... ..................................................................... Date of disclosure 17/05/2006Contact name Kelly-Jade LedwichTelephone number 0207 545 7804Name of offeree/offeror with which connected AstraZeneca PlcNature of connection (Note 6) Advisor to the offeror Notes The Notes on Form 38.5 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange